Haemonetics grants 2,538 RSUs to director
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ABERNATHY ROBERT E reported acquisition or exercise transactions in this Form 4 filing.
Haemonetics Corp director Robert E. Abernathy received a grant of 2,538 restricted stock units (RSUs) on 2026-07-24 under the Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% one year after grant, each into one share of common stock, bringing his direct holdings to 27,519 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 2,538 | -- | -- |
Footnotes (2)
- F1. The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
- F2. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
Amended and Restated 2019 Long-Term Incentive Compensation Plan financial
contingent right financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Haemonetics (HAE) report for Robert E. Abernathy?
What is the vesting schedule for Robert E. Abernathy’s new RSUs at HAE?
What does each RSU granted to Robert E. Abernathy by Haemonetics (HAE) represent?
Under which plan were Robert E. Abernathy’s Haemonetics (HAE) RSUs granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.